---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-046001"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2024-04-11T23:59:59+00:00"
generated_at: "2026-06-03T23:49:29.627275+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Brainstorm Cell regains Nasdaq minimum market value compliance

## Summary
- Received Nasdaq notification on April 10, 2024 that it regained compliance with Listing Rule 5550(b)(2).
- Market value of listed securities was >= $35M for 11 consecutive business days (Mar 22 – Apr 9, 2024).
- Previous deficiency notice received November 6, 2023; matter now closed.
- Continued listing on Nasdaq Capital Market is no longer in jeopardy.
- Press release issued April 11, 2024 confirms compliance reinstatement.

## SEC filing metadata
- accession: 0001104659-24-046001
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2024-04-11T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465924046001/0001104659-24-046001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465924046001/tm2411567d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-046001
- JSON: https://secwatch.observer/filing/0001104659-24-046001.json
- Plain text: https://secwatch.observer/filing/0001104659-24-046001.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.